ILK-IN-2

1333146-24-9

Autophagy, Integrin, Dehydrogenase, Apoptosis, Caspase

Autophagy, Apoptosis, Cytoskeletal Signaling, Proteases/Proteasome, Metabolism

0.9931

ILK-IN-2 (OSU-T315) is a novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 μM.

CNC(=O)CCc1cc(-c2ccc(cc2)-c2ccc(cc2)C(F)(F)F)n(n1)-c1ccc(cc1)N1CCNCC1

C30H30F3N5O

533.59

Ice Packs

-20°C